Αποτελέσματα Αναζήτησης
Η μολνουπιραβίρη (molnupiravir) ενδείκνυται για τη θεραπεία της ήπιας έως μέτριας βαρύτητας της νόσου του κορωνοϊού 2019 (COVID-19) σε ενήλικες με θετικό διαγνωστικό τεστ SARS-COV-2 και που έχουν ...
Molnupiravir is a prodrug that inhibits SARS-CoV-2 replication and is used to treat mild to moderate COVID-19 in high-risk adults. It is approved in the UK and authorized in the US, but has mutagenic and public health concerns.
23 Αυγ 2023 · Molnupiravir is an experimental antiviral drug authorized by the FDA for the treatment of mild-to-moderate COVID-19 in high-risk patients. Learn about its uses, dosage, side effects, warnings, and interactions.
9 Οκτ 2021 · Το προφάρμακο του EIDD-1931 είναι το molnupiravir. Αρχικά, η εταιρία που παρασκευάζει το molnupiravir ζήτησε άδεια από το FDA για να εξετάσει το φάρμακο στην αντιμετώπιση της εποχικής γρίπης.
3 Μαρ 2022 · Molnupiravir is an oral antiviral drug that can prevent hospitalization for non-severe COVID-19 patients with the highest risk of severe disease. WHO advises active monitoring, contraception and limited use of the drug, based on new data and safety concerns.
16 Δεκ 2021 · New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute...
5 Ιαν 2022 · Learn about molnupiravir, an oral antiviral drug that can prevent severe COVID-19 in high-risk patients. Find out how it works, its side effects, its effectiveness against variants, and how to get it.
